Home ETF List About

Portfolio Holdings Detail for ISIN IE00BD8KRH84
Stock Name / FundiShares Core S&P 500 UCITS ETF GBP Hedged (Dist)
IssuerBlackrock
Entity holding fund iShares VII Public Limited Company
Entity Type
Entity LEI 549300Q7FFITMZ2PFZ28
ETF TickerGSPX.LS(GBP) CXE
ETF TickerGSPX(GBP) Euronext Amsterdam

Holdings detail for REGN

Stock NameRegeneron Pharmaceuticals Inc
TickerREGN(USD) NASDAQ
TYPECommon Stock
CountryUSA
ISINUS75886F1075
LEI549300RCBFWIRX3HYQ56

Show aggregate REGN holdings

News associated with REGN

Regeneron And Sanofi : CHMP Recommends EU Approval Of Dupixent For Chronic Spontaneous Urticaria
(RTTNews) - Regeneron Pharmaceuticals Inc. (REGN) and Sanofi announced that the European Medicines Agency's Committee for Medicinal Products for Human Use or CHMP has adopted a positive opinion recommending the approval of Dupixent (dupilumab) in the European Union for treating c - 2025-09-22 02:12:20
Peek Under The Hood: JEPQ Has 10% Upside
Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and computed the weighted average implied analyst target price for the ETF itself. - 2025-09-08 08:26:56
Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) Given Consensus Rating of “Moderate Buy” by Brokerages
Shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Get Free Report) have been given an average recommendation of “Moderate Buy” by the twenty-six analysts that are currently covering the stock, Marketbeat.com reports. One analyst has rated the stock with a sell rating, six have issued a hold rating, sixteen have assigned a buy rating and three […] - 2025-08-26 02:16:48
LABU, INCY, UTHR, REGN: ETF Outflow Alert
Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the Direxion Daily S&P Biotech Bull 3x Shares (Symbol: LABU) where we have detected an approximate $67.3 million dollar outflow -- that's a 9.4% dec - 2025-08-20 12:04:03
Regeneron Pharmaceuticals (NASDAQ:REGN) versus Cadrenal Therapeutics (NASDAQ:CVKD) Head-To-Head Analysis
Regeneron Pharmaceuticals (NASDAQ:REGN – Get Free Report) and Cadrenal Therapeutics (NASDAQ:CVKD – Get Free Report) are both medical companies, but which is the better investment? We will contrast the two companies based on the strength of their dividends, risk, analyst recommendations, valuation, institutional ownership, profitability and earnings. Volatility and Risk Regeneron Pharmaceuticals has a beta […] - 2025-08-20 02:22:48
Truist Financial Cuts Regeneron Pharmaceuticals (NASDAQ:REGN) Price Target to $812.00
Regeneron Pharmaceuticals (NASDAQ:REGN – Free Report) had its price target reduced by Truist Financial from $940.00 to $812.00 in a research note published on Monday,Benzinga reports. They currently have a buy rating on the biopharmaceutical company’s stock. REGN has been the topic of several other reports. The Goldman Sachs Group dropped their price target on […] - 2025-08-14 03:00:52
Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) Stock Position Raised by Blair William & Co. IL
Blair William & Co. IL lifted its position in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) by 2.2% in the 1st quarter, Holdings Channel reports. The fund owned 1,282 shares of the biopharmaceutical company’s stock after buying an additional 27 shares during the period. Blair William & Co. IL’s holdings in Regeneron Pharmaceuticals were worth […] - 2025-08-11 06:26:50
Harbour Investments Inc. Sells 32 Shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN)
Harbour Investments Inc. reduced its position in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) by 7.4% in the first quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 403 shares of the biopharmaceutical company’s stock after selling 32 shares during the quarter. Harbour Investments Inc.’s holdings in […] - 2025-08-07 09:40:47
We Did The Math SPYX Can Go To $58
Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and computed the weighted average implied analyst target price for the ETF itself. - 2025-08-07 08:58:54
409 Shares in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) Purchased by Arkadios Wealth Advisors
Arkadios Wealth Advisors purchased a new position in shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) in the 1st quarter, according to its most recent filing with the Securities & Exchange Commission. The fund purchased 409 shares of the biopharmaceutical company’s stock, valued at approximately $259,000. Several other institutional investors and hedge funds also […] - 2025-08-07 05:38:53
Regeneron Pharmaceuticals (NASDAQ:REGN) Stock Price Expected to Rise, BMO Capital Markets Analyst Says
Regeneron Pharmaceuticals (NASDAQ:REGN – Get Free Report) had its price target upped by stock analysts at BMO Capital Markets from $600.00 to $640.00 in a research report issued on Monday,Benzinga reports. The firm currently has an “outperform” rating on the biopharmaceutical company’s stock. BMO Capital Markets’ price target indicates a potential upside of 12.30% from […] - 2025-08-06 03:12:48
Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) Receives $828.86 Consensus Target Price from Brokerages
Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Get Free Report) has been given a consensus rating of “Moderate Buy” by the twenty-four ratings firms that are currently covering the firm, Marketbeat.com reports. One investment analyst has rated the stock with a sell recommendation, six have issued a hold recommendation, fifteen have assigned a buy recommendation and two […] - 2025-08-04 02:59:01
Stocks Slump on Tariffs and Weak US Job Growth
The S&P 500 Index ($SPX ) (SPY ) today is down -1.70%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is down -1.48%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is down -2.01%. September E-mini S&P futures (ESU25 ) are down -1.75%, and September E-mini Nasdaq futures... - 2025-08-01 19:31:54
Stocks Slump on Tariffs and Weak US Job Growth
The S&P 500 Index ($SPX ) (SPY ) today is down -1.70%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is down -1.48%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is down -2.01%. September E-mini S&P futures (ESU25 ) are down -1.75%, and September E-mini Nasdaq futures... - 2025-08-01 14:40:40
Stocks Slump on Tariffs and Weak US Job Growth
The S&P 500 Index ($SPX ) (SPY ) today is down -1.70%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is down -1.48%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is down -2.01%. September E-mini S&P futures (ESU25 ) are down -1.75%, and September E-mini Nasdaq futures... - 2025-08-01 14:35:36
Stocks Slump on Tariffs and Weak US Job Growth
The S&P 500 Index ($SPX ) (SPY ) today is down -1.70%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is down -1.48%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is down -2.01%. September E-mini S&P futures (ESU25 ) are down -1.75%, and September E-mini Nasdaq futures... - 2025-08-01 14:02:25
Nasdaq 100 Movers: MRVL, REGN
In early trading on Friday, shares of Regeneron Pharmaceuticals, topped the list of the day's best performing components of the Nasdaq 100 index, trading up 3.6%. Year to date, Regeneron Pharmaceuticals, has lost about 20.7% of its value. And the worst performing Nasdaq 100 co - 2025-08-01 11:30:09
Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) Shares Purchased by Choreo LLC
Choreo LLC boosted its holdings in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) by 0.9% during the first quarter, according to its most recent Form 13F filing with the SEC. The fund owned 3,746 shares of the biopharmaceutical company’s stock after acquiring an additional 32 shares during the period. Choreo LLC’s holdings in Regeneron Pharmaceuticals […] - 2025-07-24 07:22:56
Crestwood Advisors Group LLC Grows Stock Holdings in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN)
Crestwood Advisors Group LLC increased its position in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) by 5.7% in the 1st quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 467 shares of the biopharmaceutical company’s stock after purchasing an additional 25 shares during the quarter. Crestwood Advisors Group […] - 2025-07-24 05:47:12
Kestra Private Wealth Services LLC Has $1.31 Million Stock Holdings in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN)
Kestra Private Wealth Services LLC grew its holdings in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) by 6.9% in the first quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 2,058 shares of the biopharmaceutical company’s stock after buying an additional 132 shares during the quarter. […] - 2025-07-23 07:50:58
Larson Financial Group LLC Has $34,000 Stock Holdings in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN)
Larson Financial Group LLC lessened its position in shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) by 34.6% during the 1st quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 53 shares of the biopharmaceutical company’s stock after selling 28 shares during the quarter. Larson […] - 2025-07-23 06:30:53
Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) Shares Purchased by Alps Advisors Inc.
Alps Advisors Inc. raised its position in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) by 71.0% during the 1st quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 530 shares of the biopharmaceutical company’s stock after purchasing an additional 220 shares during the quarter. Alps Advisors Inc.’s […] - 2025-07-17 05:50:54
Stratos Wealth Partners LTD. Sells 115 Shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN)
Stratos Wealth Partners LTD. trimmed its position in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) by 18.5% in the first quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 506 shares of the biopharmaceutical company’s stock after selling 115 shares during the period. Stratos Wealth Partners […] - 2025-07-16 04:58:54
Allworth Financial LP Reduces Position in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN)
Allworth Financial LP trimmed its stake in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) by 14.3% in the 1st quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 821 shares of the biopharmaceutical company’s stock after selling 137 shares during the period. Allworth Financial […] - 2025-07-15 08:20:00
Regeneron Pharmaceuticals (NASDAQ:REGN) Price Target Raised to $584.00
Regeneron Pharmaceuticals (NASDAQ:REGN – Free Report) had its price target increased by UBS Group from $560.00 to $584.00 in a report issued on Friday,Benzinga reports. The brokerage currently has a neutral rating on the biopharmaceutical company’s stock. Several other research analysts also recently commented on REGN. BMO Capital Markets reduced their price objective on Regeneron […] - 2025-07-14 03:30:48
Brown Advisory Inc. Reduces Holdings in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN)
Brown Advisory Inc. lowered its stake in shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) by 5.5% during the 1st quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 4,269 shares of the biopharmaceutical company’s stock after selling 247 shares during the quarter. Brown Advisory Inc.’s […] - 2025-07-13 05:54:54
Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) Stock Holdings Cut by D.A. Davidson & CO.
D.A. Davidson & CO. reduced its position in shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) by 2.8% in the first quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 732 shares of the biopharmaceutical company’s stock after selling 21 shares during the quarter. D.A. […] - 2025-07-11 05:32:52
Brokerages Set Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) PT at $813.57
Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Get Free Report) has received an average recommendation of “Moderate Buy” from the twenty-five ratings firms that are covering the stock, MarketBeat reports. One research analyst has rated the stock with a sell rating, six have issued a hold rating, fifteen have assigned a buy rating and three have issued […] - 2025-07-10 03:07:00
DAVENPORT & Co LLC Makes New Investment in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN)
DAVENPORT & Co LLC purchased a new position in shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) during the first quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor purchased 427 shares of the biopharmaceutical company’s stock, valued at approximately $271,000. A number of other institutional […] - 2025-07-09 05:11:22
Bessemer Group Inc. Sells 3,860 Shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN)
Bessemer Group Inc. decreased its position in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) by 76.0% in the 1st quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 1,218 shares of the biopharmaceutical company’s stock after selling 3,860 shares during the period. Bessemer Group […] - 2025-07-01 05:46:52

iShares Core S&P 500 UCITS ETF GBP Hedged (Dist) REGN holdings

DateNumber of REGN Shares HeldBase Market Value of REGN SharesLocal Market Value of REGN SharesChange in REGN Shares HeldChange in REGN Base ValueCurrent Price per REGN Share HeldPrevious Price per REGN Share Held
2025-11-11 (Tuesday)242,995USD 163,912,277REGN holding increased by 4813731USD 163,912,2770USD 4,813,731 USD 674.55 USD 654.74
2025-11-10 (Monday)242,995REGN holding increased by 112USD 159,098,546REGN holding decreased by -604313USD 159,098,546112USD -604,313 USD 654.74 USD 657.53
2025-11-07 (Friday)242,883USD 159,702,859REGN holding increased by 2589133USD 159,702,8590USD 2,589,133 USD 657.53 USD 646.87
2025-11-06 (Thursday)242,883REGN holding decreased by -70USD 157,113,726REGN holding increased by 605833USD 157,113,726-70USD 605,833 USD 646.87 USD 644.19
2025-11-05 (Wednesday)242,953REGN holding decreased by -42USD 156,507,893REGN holding increased by 3907033USD 156,507,893-42USD 3,907,033 USD 644.19 USD 628
2025-11-04 (Tuesday)242,995REGN holding decreased by -175USD 152,600,860REGN holding decreased by -3575073USD 152,600,860-175USD -3,575,073 USD 628 USD 642.25
2025-11-03 (Monday)243,170USD 156,175,933REGN holding decreased by -2322273USD 156,175,9330USD -2,322,273 USD 642.25 USD 651.8
2025-10-31 (Friday)243,170REGN holding decreased by -28USD 158,498,206REGN holding decreased by -563014USD 158,498,206-28USD -563,014 USD 651.8 USD 654.04
2025-10-30 (Thursday)243,198REGN holding increased by 98USD 159,061,220REGN holding increased by 338799USD 159,061,22098USD 338,799 USD 654.04 USD 652.91
2025-10-29 (Wednesday)243,100REGN holding increased by 98USD 158,722,421REGN holding decreased by -317528USD 158,722,42198USD -317,528 USD 652.91 USD 654.48
2025-10-28 (Tuesday)243,002REGN holding increased by 420USD 159,039,949REGN holding increased by 17054279USD 159,039,949420USD 17,054,279 USD 654.48 USD 585.31
2025-10-27 (Monday)242,582REGN holding increased by 224USD 141,985,670REGN holding increased by 1914864USD 141,985,670224USD 1,914,864 USD 585.31 USD 577.95
Share price and value of shares held is calculated on the adjusted close price of each day (row). Changes between days reflect the gain/loss of the portfolio as a result of changes in the adjusted close price and changes in the holdings

Share Trades of REGN by Blackrock for IE00BD8KRH84

Show aggregate share trades of REGN

DateActionQuantityMarket HighMarket LowLikely Trade PriceLikely Trade Value (Profit/Loss)Average Price previous trades
2025-11-10BUY112665.990653.190 654.470USD 73,301 638.75
2025-11-06SELL-70657.000641.260 642.834USD -44,998 638.62 Loss of -295 on sale
2025-11-05SELL-42646.895628.000 629.890USD -26,455 638.59 Profit of 365 on sale
2025-11-04SELL-175646.221625.140 627.248USD -109,768 638.64 Profit of 1,994 on sale
2025-10-31SELL-28659.760645.000 646.476USD -18,101 638.56 Loss of -222 on sale
2025-10-30BUY98664.000645.000 646.900USD 63,396 638.48
2025-10-29BUY98652.910659.980 659.273USD 64,609 638.40
2025-10-28BUY420654.480655.700 655.578USD 275,343 638.32
2025-10-27BUY224585.310586.150 586.066USD 131,279 638.59
2025-10-24BUY28577.950582.700 582.225USD 16,302 638.91
2025-10-23SELL-56575.690584.000 583.169USD -32,657 639.25 Profit of 3,140 on sale
2025-10-22BUY112584.740588.710 588.313USD 65,891 639.54
2025-10-21BUY42579.340582.410 582.103USD 24,448 639.86
2025-10-17BUY210578.050579.040 578.941USD 121,578 640.54
2025-10-16BUY14569.170589.080 587.089USD 8,219 640.92
2025-10-14SELL-84572.600576.180 575.822USD -48,369 641.65 Profit of 5,530 on sale
2025-10-07BUY420583.240591.450 590.629USD 248,064 641.98
2025-10-06BUY14585.480603.650 601.833USD 8,426 642.29
2025-10-03BUY196600.000618.010 616.209USD 120,777 642.53
2025-10-02BUY154600.000605.410 604.869USD 93,150 642.77
2025-10-01BUY98599.940615.390 613.845USD 60,157 643.01
2025-09-30BUY140562.270574.040 572.863USD 80,201 643.47
2025-09-29BUY126560.750564.910 564.494USD 71,126 643.94
2025-09-26BUY154563.900564.610 564.539USD 86,939 644.40
2025-09-25BUY196555.510579.000 576.651USD 113,024 644.91
2025-09-24SELL-4,866576.980577.980 577.880USD -2,811,964 645.31 Profit of 328,101 on sale
2025-09-18BUY14598.710600.000 599.871USD 8,398 645.58
2025-09-17BUY126585.500587.670 587.453USD 74,019 645.93
2025-09-16BUY56575.060579.400 578.966USD 32,422 646.35
2025-09-15BUY140572.590573.690 573.580USD 80,301 646.79
2025-09-12BUY42560.000570.000 569.000USD 23,898 647.31
2025-09-11BUY70568.200570.760 570.504USD 39,935 647.79
2025-09-09BUY70556.530563.570 562.866USD 39,401 648.90
2025-08-12BUY42556.550562.740 562.121USD 23,609 650.01
2025-08-11BUY126545.940572.580 569.916USD 71,809 650.66
2025-08-08BUY322563.000567.690 567.221USD 182,645 651.21
2025-08-07BUY42559.800565.480 564.912USD 23,726 651.78
2025-08-01BUY252558.870583.280 580.839USD 146,371 652.37
2025-07-31SELL-2,214545.460558.130 556.863USD -1,232,895 653.05 Profit of 212,963 on sale
2025-07-30BUY112554.580563.590 562.689USD 63,021 653.68
2025-07-29BUY14558.150559.610 559.464USD 7,832 654.30
2025-07-14BUY112570.590575.130 574.676USD 64,364 654.84
2025-07-11SELL-28567.740568.460 568.388USD -15,915 655.41 Profit of 2,437 on sale
2025-07-10BUY112559.760566.370 565.709USD 63,359 656.04
2025-07-09BUY112552.580558.380 557.800USD 62,474 656.73
2025-07-08BUY86547.750559.460 558.289USD 48,013 657.45
2025-07-07SELL-322538.110547.590 546.642USD -176,019 658.25 Profit of 35,939 on sale
2025-07-02SELL-406547.740551.500 551.124USD -223,756 660.53 Profit of 44,419 on sale
2025-06-30BUY238525.000526.080 525.972USD 125,181 661.47
2025-06-27BUY126521.000531.210 530.189USD 66,804 662.44
2025-06-25SELL-28520.290525.630 525.096USD -14,703 664.44 Profit of 3,902 on sale
2025-06-24BUY18522.270527.450 526.932USD 9,485 665.45
2025-06-23BUY364511.920516.180 515.754USD 187,734 666.54
2025-06-20SELL-42509.720521.310 520.151USD -21,846 667.67 Profit of 6,196 on sale
2025-06-18SELL-84513.580519.170 518.611USD -43,563 669.92 Profit of 12,710 on sale
2025-06-13SELL-42529.240529.550 529.519USD -22,240 672.16 Profit of 5,991 on sale
2025-06-12BUY42521.840525.220 524.882USD 22,045 673.28
2025-06-11BUY56518.600528.370 527.393USD 29,534 674.44
2025-06-06SELL-70493.220499.880 499.214USD -34,945 678.20 Profit of 12,529 on sale
2025-06-05SELL-42483.070491.770 490.900USD -20,618 679.71 Profit of 7,930 on sale
2025-06-04SELL-56484.930499.900 498.403USD -27,911 681.24 Profit of 10,239 on sale
2025-06-02BUY182490.810502.560 501.385USD 91,252 684.28
2025-05-30SELL-42490.280519.780 516.830USD -21,707 685.83 Profit of 7,098 on sale
2025-05-29BUY14605.390605.730 605.696USD 8,480 686.48
2025-05-28SELL-14591.850606.000 604.585USD -8,464 687.25 Profit of 1,157 on sale
2025-05-27BUY154603.260608.170 607.679USD 93,583 687.94
2025-05-23SELL-280588.340591.640 591.310USD -165,567 689.60 Profit of 27,522 on sale
2025-05-22SELL-308596.850605.500 604.635USD -186,228 690.38 Profit of 26,410 on sale
2025-05-21BUY14604.620617.520 616.230USD 8,627 691.11
2025-05-20BUY112614.790615.450 615.384USD 68,923 691.76
2025-05-19BUY406596.540598.560 598.358USD 242,933 692.58
2025-05-16BUY378594.320595.190 595.103USD 224,949 693.43
2025-05-15BUY308584.990585.260 585.233USD 180,252 694.39
2025-05-14BUY280571.360580.560 579.640USD 162,299 695.47
2025-05-13SELL-56574.160575.050 574.961USD -32,198 696.56 Profit of 6,809 on sale
2025-05-12BUY14575.630577.990 577.754USD 8,089 697.65
2025-05-09BUY42527.780552.840 550.334USD 23,114 699.19
2025-05-08SELL-406547.670552.570 552.080USD -224,144 700.58 Profit of 60,292 on sale
2025-05-07SELL-196560.930568.130 567.410USD -111,212 701.87 Profit of 26,355 on sale
2025-05-06BUY490558.520606.870 602.035USD 294,997 703.21
2025-05-02BUY42605.610615.610 614.610USD 25,814 705.09
2025-05-01SELL-70590.000593.930 593.537USD -41,548 706.20 Profit of 7,886 on sale
2025-04-30BUY42598.760600.200 600.056USD 25,202 707.24
2025-04-29BUY98568.910579.980 578.873USD 56,730 708.60
2025-04-28BUY223610.860614.830 614.433USD 137,019 709.57
2025-04-25BUY210602.640602.790 602.775USD 126,583 710.64
2025-04-24BUY60599.760601.280 601.128USD 36,068 711.76
2025-04-23BUY165587.850603.770 602.178USD 99,359 713.02
2025-04-22SELL-92585.490587.100 586.939USD -53,998 714.34 Profit of 11,720 on sale
2025-04-17BUY30563.160564.210 564.105USD 16,923 719.18
2025-04-16BUY1,002549.280561.830 560.575USD 561,696 721.00
2025-04-15BUY280557.910575.200 573.471USD 160,572 722.78
2025-04-11BUY350554.180555.530 555.395USD 194,388 726.34
2025-04-10BUY574546.390571.990 569.430USD 326,853 728.36
2025-04-09BUY112576.720580.730 580.329USD 64,997 730.08
2025-04-08BUY294556.810586.030 583.108USD 171,434 732.07
2025-04-07BUY336572.780591.540 589.664USD 198,127 733.93
2025-04-04SELL-840573.450612.990 609.036USD -511,590 735.81 Profit of 106,493 on sale
2025-04-02BUY98625.600628.000 627.760USD 61,520 737.13
2025-03-31SELL-378634.230640.720 640.071USD -241,947 739.85 Profit of 37,715 on sale
2025-03-28SELL-238637.360642.970 642.409USD -152,893 741.11 Profit of 23,491 on sale
2025-03-27SELL-70635.830643.430 642.670USD -44,987 742.43 Profit of 6,983 on sale
2025-03-26BUY126640.140644.000 643.614USD 81,095 743.72
2025-03-25SELL-168634.140662.570 659.727USD -110,834 745.13 Profit of 14,347 on sale
2025-03-24BUY98661.000667.460 666.814USD 65,348 746.22
2025-03-21BUY168658.480661.000 660.748USD 111,006 747.37
2025-03-19BUY28672.360674.570 674.349USD 18,882 749.53
2025-03-18SELL-252664.960678.270 676.939USD -170,589 750.69 Profit of 18,585 on sale
2025-03-17BUY266678.420679.830 679.689USD 180,797 751.69
2025-03-14BUY238666.870686.980 684.969USD 163,023 752.89
2025-03-13BUY1,176680.610698.950 697.116USD 819,808 753.92
2025-03-12BUY560689.500712.460 710.164USD 397,692 754.86
2025-03-11BUY224718.160747.700 744.746USD 166,823 755.39
2025-03-07BUY134707.510729.750 727.526USD 97,488 756.28
2025-03-06SELL-126698.440701.000 700.744USD -88,294 757.17 Profit of 7,110 on sale
2025-03-05BUY434687.150692.790 692.226USD 300,426 758.26
2025-03-04BUY84675.490697.460 695.263USD 58,402 759.58
2025-03-03BUY378684.870704.640 702.663USD 265,607 760.78
2025-02-28SELL-98698.740708.580 707.596USD -69,344 761.80 Profit of 5,312 on sale
2025-02-27BUY14702.780721.000 719.178USD 10,068 762.78
2025-02-26SELL-28706.940721.410 719.963USD -20,159 763.73 Profit of 1,225 on sale
2025-02-25BUY266723.470739.000 737.447USD 196,161 764.42
2025-02-21BUY196700.330704.080 703.705USD 137,926 766.48
2025-02-20BUY112696.020703.140 702.428USD 78,672 767.76
2025-02-19BUY28685.660688.670 688.369USD 19,274 769.28
2025-02-18BUY70680.000689.950 688.955USD 48,227 770.97
2025-02-13BUY238674.270677.690 677.348USD 161,209 776.80
2025-02-12BUY84663.860670.980 670.268USD 56,303 779.10
2025-02-11SELL-28665.460680.790 679.257USD -19,019 781.47 Profit of 2,862 on sale
2025-02-07SELL-112710.000731.420 729.278USD -81,679 785.00 Profit of 6,241 on sale
2025-02-06BUY56722.070734.270 733.050USD 41,051 786.40
2025-02-04BUY490697.050709.980 708.687USD 347,257 790.10
2025-02-03BUY182666.850673.650 672.970USD 122,481 793.04
2025-01-31BUY42672.980688.000 686.498USD 28,833 795.96
2025-01-30BUY28683.080689.620 688.966USD 19,291 798.79
2025-01-29BUY266687.270697.570 696.540USD 185,280 801.65
2025-01-28BUY126686.330690.300 689.903USD 86,928 804.68
2025-01-27BUY196684.710698.450 697.076USD 136,627 807.92
2025-01-24BUY126675.790693.840 692.035USD 87,196 811.59
2025-01-23BUY364694.640696.190 696.035USD 253,357 814.94
2025-01-22BUY238680.030699.880 697.895USD 166,099 818.90
2024-12-10BUY105778.500791.490 790.191USD 82,970 820.13
2024-12-09BUY120788.000800.990 799.691USD 95,963 821.13
2024-12-06BUY180778.000778.120 778.108USD 140,059 822.52
2024-12-05BUY45767.900768.020 768.008USD 34,560 824.34
2024-12-04BUY165754.260756.130 755.943USD 124,731 826.76
2024-12-03BUY531749.570770.000 767.957USD 407,785 829.52
2024-12-02BUY44762.340763.890 763.735USD 33,604 832.00
2024-11-29SELL-384750.220754.510 754.081USD -289,567 835.15 Profit of 31,131 on sale
2024-11-27BUY405754.870762.160 761.431USD 308,380 841.84
2024-11-26BUY870753.030754.180 754.065USD 656,037 845.70
2024-11-25BUY900749.510757.860 757.025USD 681,322 850.07
2024-11-22BUY1,050738.000751.400 750.060USD 787,563 855.41
2024-11-21BUY165744.500757.560 756.254USD 124,782 860.96
2024-11-20BUY150743.350750.690 749.956USD 112,493 867.15
2024-11-19BUY135744.600758.600 757.200USD 102,222 873.95
2024-11-18BUY1,215762.000762.700 762.630USD 926,595 880.54
2024-11-12BUY420821.000831.000 830.000USD 348,600 884.26
2024-11-11BUY285825.680834.420 833.546USD 237,561 888.17
2024-11-08BUY218828.420830.730 830.499USD 181,049 892.43
2024-11-07BUY1,335824.480832.530 831.725USD 1,110,353 897.66
2024-11-06BUY405816.650844.510 841.724USD 340,898 904.41
2024-11-05BUY596829.430836.630 835.910USD 498,202 911.23
2024-11-04BUY105828.840852.010 849.693USD 89,218 919.47
2024-11-01BUY240843.600862.000 860.160USD 206,438 927.90
2024-10-31BUY60838.200883.150 878.655USD 52,719 939.11
2024-10-30BUY149922.790935.860 934.553USD 139,248 941.44
2024-10-29BUY360927.330932.380 931.875USD 335,475 943.79
2024-10-28SELL-105928.610943.270 941.804USD -98,889 946.83 Profit of 528 on sale
2024-10-25BUY180933.020943.830 942.749USD 169,695 950.28
2024-10-24BUY120928.900952.020 949.708USD 113,965 957.41
2024-10-23BUY150941.390959.600 957.779USD 143,667 965.42
2024-10-22BUY387962.340972.750 971.709USD 376,051 968.50
2024-10-21BUY420968.500991.240 988.966USD 415,366 0.00
Market high and low price is on the date.

* (if shown) = market close price used not a projected price. This is used when we do not have market data available to calculate a projection

The likely trade price/value is our estimate on the likely price the trade took place at and is not the actual trade price. The likely LOSS/GAIN is our estimate. Where a profit/loss value is shown in the Likely Trade Value column, this is derived from matching trades between periods eg the most recent previous BUY is matched with the SELL for the same number of shares and the difference between the likely BUY price and likely SELL price is calculated. Where a profit or loss is shown in the Average Price of Previous Trades column, this is dervied using the likely trade price compared to the average of previous trades based on adjusted close

Shorting History of REGN

DateShorted VolumeShort Exempt VolumeTotal Shares Traded% Shorted
2025-09-19208,6591,635312,81266.7%
2025-09-18236,4853,679387,51961.0%
2025-09-17229,191716370,89561.8%
2025-09-16173,632584271,02064.1%
2025-09-15204,491251334,49661.1%
2025-09-12117,50433222,76052.7%
2025-09-11125,4783,137286,51643.8%
2025-09-10195,068481339,88557.4%
2025-09-09129,168994274,52047.1%
2025-09-08250,895396527,06247.6%
2025-09-05170,149290289,56658.8%
2025-09-04188,2272,103360,61952.2%
2025-09-03185,679344438,11142.4%
2025-09-02191,954138476,28840.3%
2025-08-29133,226685236,72656.3%
2025-08-28116,5602,177256,67545.4%
2025-08-27113,719465243,83646.6%
2025-08-26210,376450400,19952.6%
2025-08-25149,13068363,37741.0%
2025-08-22211,8223,244701,77030.2%
2025-08-21257,4923,416446,43957.7%
2025-08-20327,738572559,13358.6%
2025-08-19118,4722,191324,31136.5%
2025-08-18146,282388277,90952.6%
2025-08-15209,9233,375441,75247.5%
2025-08-14157,5693,623429,32736.7%
2025-08-13111,342233362,78630.7%
2025-08-12117,647171310,77537.9%
2025-08-11129,5132,676284,75745.5%
2025-08-08128,5591,038431,84129.8%
2025-08-07166,6481,560352,87747.2%
2025-08-06176,311624397,08944.4%
2025-08-05154,257115353,74443.6%
2025-08-04200,7581,913409,89749.0%
2025-08-01349,7753,745728,72048.0%
2025-07-31222,350476549,34440.5%
2025-07-30106,8391,689231,76146.1%
2025-07-29149,359276292,66751.0%
2025-07-28103,6871,380245,28742.3%
2025-07-25103,783556259,06940.1%
2025-07-24156,9742,397291,67753.8%
2025-07-23168,7341,708355,37247.5%
2025-07-22116,324617304,88038.2%
2025-07-2198,482900250,10739.4%
2025-07-18183,1741,051391,90946.7%

The data here is derived from FINRA daily shorted trade data. The Daily Short Sale Volume is the total volume of short trades that meet certain criteria on each trade date by 6 PM ET on the trade date. The detail trade data is derived from the monthly shorted trade data which will differ in aggregate. The detail trade data is derived from the transaction level data and includes ALL trades (including exempt) and the aggregation period extends beyond 6pm.

Back to Listing

Disclaimer

All information is provided as is without warranty and should be used for indicative purposes only. You should independently check data before making any investment decision. This information is derived from third party sources and we cannot guarantee that their data is current, accurate, complete, free from defects etc and we therefore accept no responsibility for how it may be used. We accept no liability for the reliability or accuracy of the data provided. We are not making recommendations for any financial instruments listed on this website.